Susac syndrome (Q87304): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Síndrome de Susac, também conhecida como SICRET (pequenos infartos em cóclea, retina e tecido encefálico) e RED-M (microangiopatia associada a retinopatia, encefalopatia e surdez), é uma vasculite de pequenos vasos com microinfartos decorrentes de oclusões arteriolares. A síndrome é caracterizada pela tríade de: encefalopatia, surdez neurossensorial usualmente bilateral e oclusões de ramo da artéria retiniana.
description / endescription / en
 
Susac syndrome, also referred to as SICRET (Small Infarctions of Cochlear, Retinal and Encephalic Tissue) and RED-M (Retinopathy, encephalopathy, deafness associated microangiopathy) is a small vessel vasculitis with microinfarction due to arteriolar occlusions. The syndrome is characterised by the triad of: encephalopathy, neurosensory hearing loss usually bilateral and branch retinal artery occlusions.

Revision as of 12:52, 15 August 2026

Susac syndrome, also referred to as SICRET (Small Infarctions of Cochlear, Retinal and Encephalic Tissue) and RED-M (Retinopathy, encephalopathy, deafness associated microangiopathy) is a small vessel vasculitis with microinfarction due to arteriolar occlusions. The syndrome is characterised by the triad of: encephalopathy, neurosensory hearing loss usually bilateral and branch retinal artery occlusions.
Language Label Description Also known as
default for all languages
ID_1292480458
    English
    Susac syndrome
    Susac syndrome, also referred to as SICRET (Small Infarctions of Cochlear, Retinal and Encephalic Tissue) and RED-M (Retinopathy, encephalopathy, deafness associated microangiopathy) is a small vessel vasculitis with microinfarction due to arteriolar occlusions. The syndrome is characterised by the triad of: encephalopathy, neurosensory hearing loss usually bilateral and branch retinal artery occlusions.

      Statements